We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 153.00
Bid: 146.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 14.00 (9.589%)
Open: 153.00
High: 153.00
Low: 153.00
Prev. Close: 153.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Feb 2024 07:00

RNS Number : 5231E
Itaconix PLC
27 February 2024
 

For release: 07.00, 27 February 2024

 

Itaconix plc

("Itaconix" or the "Company")

Trading Update

Another record year of revenues

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to provide a trading update and report that trading is in line with current expectations.

Itaconix achieved another record year with unaudited revenues of $7.9 million, a substantial increase of 40.6% over FY22 of $5.6 million. The Company has now grown revenues at a compound annual growth rate of 54.9% since 2018. Europe led this year's growth rate, with revenues increasing by 89.3% to $1.0 million, while North America continued to generate significant increases, with revenues growing by 35.6% to $6.9 million.

The Cleaning Sector was the major revenue contributor, generating $7.2 million in unaudited revenues, a 43.7% increase compared to FY22. This growth is attributed to expanding detergent sales volumes across North America and Europe, bolstered by increased volume from existing customers in North America and notable successes in acquiring new detergent customers in Europe.

Although Itaconix ingredients increase sustainability, the Company's key competitive advantage is in delivering both performance and affordability, which remain major concerns for brands, retailers, and consumers alike. Cleaning Sector revenues consisted of $5.3 million for Performance Ingredients and $1.9 million for Formulated Solutions. The Company anticipates further growth as awareness of Itaconix's competitive advantages (performance, cost and sustainability) continues to expand in North America and Europe.

The Hygiene and Beauty Sectors contributed revenues of $0.6 million over the period, representing a 31.4% increase over FY22. Renewed growth is coming from higher volumes to existing customers and increasing traction with new customers for the Company's odour neutralizing ingredients.

Itaconix is also making significant progress in developing new products, including superabsorbent polymers, a new water-soluble polymer, and the application of BIO*Asterix ingredients in paints and leather, opening up exciting new revenue streams.

Unaudited net cash and investments as at 31 December 2023 was $10.0 million (2022: $0.6 million).

Further details of FY23 trading and the outlook for 2024 will be provided when the Company announces FY23 results planned for early April 2024.

John R. Shaw, CEO of Itaconix, commented:

"We have completed another record-setting year with revenues again growing substantially. This is being driven by both new customer wins and an expanding base of recurring revenues from existing customers. Our strong balance sheet is enabling us to target new customers and product innovation to underpin our growth objectives. With our commercial advancements and the development of new revenue opportunities, we are well placed to fulfil our strategy of becoming a large, profitable specialty ingredient company, distinguished by our commitment to safer chemicals, superior performance, cost-efficiency, and sustainability."

 

- Ends -

 

Itaconix plc

John R. Shaw / Laura Denner

+1 603 775-4400

Belvedere Communications

John West / Llew Angus

+44 (0)20 7653 8702

Canaccord Genuity - Nominated Adviser and Sole Broker

Adam James / Harry Pardoe

+44 (0) 20 7523 8000

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products.? The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.£ 

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBGDDSDDDGSL
Date   Source Headline
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
22nd Aug 20237:00 amRNSShare Consolidation & Total Voting Rights
15th Aug 20237:00 amRNSShare Consolidation
12th Jul 20237:00 amRNSTrading Update
28th Jun 202312:29 pmRNSAGM Statement
5th Jun 20237:00 amRNSFinal Results
24th May 20237:00 amRNSNotice of Final Results, Briefings, and AGM
25th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
2nd Mar 20233:25 pmRNSTR-1
1st Mar 20237:00 amRNSAward from Frost & Sullivan
28th Feb 20236:03 pmRNSTR-1
28th Feb 20235:04 pmRNSTR-1
28th Feb 20233:09 pmRNSTR-1
23rd Feb 20237:00 amRNSTR-1
22nd Feb 202312:28 pmRNSResults of Open Offer, GM and Total Voting Rights
15th Feb 20237:00 amRNSInvestor Presentation following GM on 22 Feb 2023
3rd Feb 20237:00 amRNSPlacing, Subscription and Open Offer; Notice of GM
5th Jan 20237:00 amRNSBoard Change
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20227:00 amRNSItaconix and Brenntag Promote Sustainable Cleaning
14th Sep 20227:00 amRNSHalf year results
13th Sep 202211:05 amRNSSecond Price Monitoring Extn
13th Sep 202211:00 amRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSItaconix and Croda Renew Supply Agreement
20th Jul 20227:00 amRNSBoard Change
13th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSDirectorate Change
1st Jul 20222:37 pmRNSResult of AGM
1st Jul 20229:00 amRNSPrice Monitoring Extension
1st Jul 20227:00 amRNSAGM Statement and Notice of Capital Markets Event
29th Jun 20227:00 amRNSNotice of Capital Markets Webinar
8th Jun 20229:04 amRNSFinal Results - replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.